Vivos Gets FDA Nod for Sleep Apnea Oral Device, While Philips Wrestles With Yet Another CPAP Safety Issue

Vivos Therapeutics achieved a first in obtaining FDA clearance of its removable oral appliance for severe obstructive sleep apnea — an alternative to continuous positive airway pressure (CPAP) or surgical implants — while Philips Respironics deals with potential overheating issues in its DreamStation 2 CPAP devices.
Source: Drug Industry Daily